BRIEF published on 04/11/2025 at 11:28, 7 months 23 days ago PLANOPTIK AG Reports on 2024 Performance and Future Prospects Sensor Technology Annual Report Sales Decline Production Expansion Financial Outlook
PRESS RELEASE published on 04/11/2025 at 11:23, 7 months 23 days ago PLANOPTIK AG: Annual Report 2024 PLANOPTIK AG has released its Annual Report for 2024, highlighting the impact of cyclical influences on Group sales and future growth opportunities in sensor technology and microfluidics Sensor Technology Annual Report Group Sales PLANOPTIK AG Microfluidics
BRIEF published on 03/28/2025 at 17:11, 8 months 7 days ago PLANOPTIK AG Reports 2024 Financial Results and 2025 Outlook Revenue Decline Financial Results 2024 2025 Outlook Customer Inventory EBITDA And EBT
PRESS RELEASE published on 03/28/2025 at 17:06, 8 months 7 days ago PLANOPTIK AG: PLANOPTIK AG confirms its 2024 annual figures, reporting a decrease in revenue and earnings. The company expects sales and earnings to improve in 2025, with further growth anticipated in 2026. Details in the full annual report on April 11, 2025 Financial Year 2024 Outlook 2025 PLANOPTIK AG Annual Figures
BRIEF published on 03/13/2025 at 10:59, 8 months 22 days ago PLANOPTIK AG Reports Decline in 2024 Revenue but Hopes for 2025 Recovery Financial Outlook EBITDA Decline 2024 Revenue PLANOPTIK AG 2025 Forecast
PRESS RELEASE published on 03/13/2025 at 10:54, 8 months 22 days ago EQS-Adhoc: PLANOPTIK AG: Preliminary figures for 2024 and outlook PLANOPTIK AG reports preliminary figures for 2024 with revenue at EUR 11,861 thousand, showing a decrease from the previous year. Despite challenges, expects improved revenue in 2025 Revenue Outlook 2024 Preliminary Figures PLANOPTIK AG
BRIEF published on 08/02/2024 at 08:46, 1 year 4 months ago PLANOPTIK AG: Half-year figures 2024 and outlook 2024 Outlook Sales Decline Half-year Results Future Growth PLANOPTIK AG
PRESS RELEASE published on 08/02/2024 at 08:41, 1 year 4 months ago EQS-Adhoc: PLANOPTIK AG: Half-year figures 2024 and outlook PLANOPTIK AG reported a decrease in consolidated sales and earnings in the first half of 2024, with expectations of continued lower figures for the full year, but anticipates significant growth from 2025 onwards Outlook Earnings Growth Half-year Results Consolidated Sales PLANOPTIK AG
BRIEF published on 07/22/2024 at 15:54, 1 year 4 months ago Plan Optik AG Plans Switch to Regulated Market Shareholders Frankfurt Stock Exchange Transparency Regulated Market Plan Optik AG
PRESS RELEASE published on 07/22/2024 at 15:49, 1 year 4 months ago EQS-Adhoc: PLANOPTIK AG: PLANOPTIK AG aims to switch to the regulated market PLANOPTIK AG plans to switch to the regulated market (General Standard) from the Basic Board of the Frankfurt Stock Exchange, aiming to enhance shareholder position and transparency Stock Exchange Transparency Regulated Market PLANOPTIK AG General Standard
Published on 12/05/2025 at 02:35, 3 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 27 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
